Skip to content
★ Sign in to follow
EJ

Eric J. Rey

CEO
Arcadia Biosciences, Inc.
Total declarations
36
Company
1
▲ Purchases (1 ops.)
€3,353
▼ Sales (18 ops.)
€1.2M

Latest filing published 27 Mar 2018 for Arcadia Biosciences, Inc., €88k.

Filing timeline

BuySale
Eric J. Rey

Insider track record

Disclosed buys
1
Disclosed sells
18
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Eric J. Rey: trading record in brief

All filings by Eric J. Rey on record concern Arcadia Biosciences, Inc. Over a trading history stretching from 23 September 2015 to 23 March 2018, the count stands at 36 filings.

Market trades split into 1 purchase (€3,353) and 18 sales (€1.2M). Taken together, the sales exceed the purchases by €1.1M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 17 option exercises. Since January 2018: no purchases and 3 sales on the market.

The newest entry dates from 27 March 2018: an option exercise of €88k, in Arcadia Biosciences, Inc. The last insider purchase was made public on 12 June 2017, 3,437 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Eric J. Rey

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations36 total

25 of 36 declarations